ABC News' Dr. Tara Narula shares what patients need to know. Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U ...

Novo Nordisk’s recent introduction of a direct-to-patient delivery model for its weight-loss drug Wegovy in the United States could potentially delay its availability in India, industry analysts ...

Yet another study is zeroing in on the unintended side effects of Novo Nordisk's semaglutide – the active ingredient in the company's blockbuster weight loss drug Wegovy and diabetes treatment ...

Novo Nordisk’s breakneck sales growth has continued in the first quarter of this year with a 24% increase that was helped by a doubling in turnover of obesity blockbuster Wegovy. Group revenues ...

Torey Van Oot at Axios reports: “Minnesota lawmakers are renewing a push to require insurance coverage of anti-obesity drugs like Ozempic and Wegovy.” CCX Media reports: “A Robbinsdale salon ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

HealthDay News — The makers of two popular weight-loss drugs — Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance. Novo Nordisk, the Danish ...

Novo Nordisk has lowered Wegovy's monthly cost by 23%, and Eli Lilly cut prices for Zepbound's starter dose to $349 per month. HealthDay News — The makers of two popular weight-loss drugs — Wegovy and ...

Novo Nordisk launched a direct-to-consumer program last week to sell Wegovy at a reduced price for people who are uninsured or insured on commercial plans that don't cover the obesity drug. Through ...

The exact price depends on dosage, pharmacy, location, insurance coverage, and available savings programs. Fully understanding the various factors affecting ...